- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 382 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 369 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 278 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 138 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 288 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 375 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 227 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 390 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 370 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 375 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 271 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 387 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 377 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 466 Pages
Global
From €5124EUR$5,850USD£4,447GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more